Speakers at Epigenetics and Epigenomics in Health and Disease 2022

A Director of Cancer Epigenetics Program, Chief of Division of Cancer Genomics & Epigenetics and Professor of Human Genetics.

Rob Martienssen is a Professor at Cold Spring Harbor Laboratory and a Howard Hughes Medical Institute.

Kristian Helin, CEO of The Institute of Cancer Research, professor at the University of London, research fellow at Harvard Medical School

Dr. Di Croce’s laboratory addresses the molecular basis of epigenetic alterations during the early phase of tumorigenesis.

Clinician-scientist at the Peter MacCallum Cancer Centre and Centre for Cancer Research University of Melbourne.

Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School.

In 1999, he moved to IGH in Montpellier, France, to set up a junior lab and stayed at IGH ever since.

John T. Wilson Distinguished Service Professor Dept. of Chemistry and Biochemistry and Molecular Biology at the University of Chicago.

Early 2019 she started her own independent lab at CSHL. The lab is interested in mechanisms of small RNA-mediated transposon control.